New Drug Targets Common Viruses and Could Treat Current and Future COVID-19 Variants, Influenza, Zika, West Nile, Hepatitis and Future Threats

ViroBlock, a startup company founded by Hebrew University of Jerusalem (HU) researchers, has developed a new drug platform for rapidly generating anti-viral drugs that target proteins common to all viruses.

U.S. Ambassador to Israel Tom Nides visited the Hebrew University in Jerusalem (HU) today, his first visit to an Israeli academic institution.  During the visit, Ambassador Nides met with senior University leaders – including the university’s president, Prof. Asher Cohen, its vice-president Amb. Yossi Gal and its rector, Prof. Barak Medina – as well as with prominent researchers and scientists. Ambassador Nides also met with university students and professors who take part in Embassy-sponsored programs and chatted with them about the importance of diversity and higher education.